Showing results (2121-2130 of 2,180) with videos related to

Sort By:
Pageof 218
European Journal of Heart Failure|July 6, 2012
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF studyG Michael Felker, Vic Hasselblad, W H Wilson Tang, et al.
Journal of the American College of Cardiology|April 18, 2015
Cardiovascular drug development: is it dead or just hibernating?Christopher B Fordyce, Matthew T Roe, Tariq Ahmad, et al.
The Journal of Rheumatology|May 3, 2017
Proceedings of the GRAPPA 2016 RetreatDeepak R Jadon, Dafna D Gladman, Philip J Mease, et al.
JAMA Dermatology|June 22, 2018
Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic ReviewAdam R Ford, Michael Siegel, Jerry Bagel, et al.
The Journal of Investigative Dermatology|February 24, 2020
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)Joel M Gelfand, Daniel B Shin, Kristina Callis Duffin, et al.
European Heart Journal|December 6, 2015
Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndromeMatthew T Roe, Derek D Cyr, Debra Eckart, et al.
The British Journal of Dermatology|July 3, 2026
Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 TrialsLinda Stein Gold, April W Armstrong, Jennifer Soung, et al.
Journal of Thrombosis and Haemostasis : JTH|March 6, 2004
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI PilotJ H Alexander, C K Dyke, H Yang, et al.
The American Journal of Cardiology|April 26, 2016
Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial)Marco Metra, Robert J Mentz, Adrian F Hernandez, et al.
Journal of the American College of Cardiology|November 12, 2013
Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)David J Whellan, Pierluigi Tricoci, Edmond Chen, et al.
Pageof 218